In 2023, AINI organized the most ambitious EQAS to date. In fact, 47 Italian and foreign laboratories have been included in the current EQAS, 16 more than in the 2022 EQAS. 10 different schemes are affected by this EQAS (oligoclonal bands, anti-AQP4, anti-MOG, anti-neuronal antigens of surface, anti-onconeural antigens, anti-gangliosides, anti-MAG, anti-paranodal antigens, anti-ACHR, anti-MUSK), which involve the use of 45 adequately aliquoted biological samples. EQAS 2023 included the following phases: EEM, as the organizational secretariat of AINI responsible for EQAS, sent a survey in Google format to all the Italian laboratories that are part of the AINI network. In [...]

by |30 Maggio 2023|Categorie: Senza categoria|0 Commenti
Torna in cima